BRANDI BARNES: Open Payments
NPI 1417254780 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 63 payments from 13 companies in 2025. Trend: 2023 $1,089 · 2024 $939 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $247 |
| Novartis Pharmaceuticals Corporation | 14 | $208 |
| Amgen Inc. | 12 | $141 |
| W. L. Gore & Associates, Inc. | 1 | $94 |
| CVRx, Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $44 |
| Abbott Laboratories | 2 | $43 |
| Boston Scientific Corporation | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
Products named: VYNDAQEL, LEQVIO, REPATHA, GORE CARDIOFORM Septal Occluder, ELIQUIS, Barostim Neo System, Wegovy, AMVUTTRA.
Industry payments across AR — which companies pay providers there.
